Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

EXPRESSION OF CHEMOKINE (C-C MOTIF) RECEPTOR 7 IN PROSTATE CANCER TISSUE OF YOUNG PATIENTS AND IN METASTATIC CANCER CELLS

View through CrossRef
Background: Chemokine (C-C motif) receptor 7 (CCR7) is a chemokine receptor involved in the carcinogenesis of several types of tumors due to its promoting action in epithelial-mesenchymal transition events, invasion, angiogenesis and metastasis. However, its role in prostate cancer (PCa) remains unclear. Aim: To evaluate CCR7 expression by immunohistochemistry in prostate tumors from young patients and to determine the possible relationship with the clinicopathological characteristics. Materials and Methods: We analyzed retrospectively paraffin-embedded tissue sections from 23 young PCa (≤ 55 years old) patients and evaluated the transcriptomic expression in the TCGA database. Results: Expression of CCR7 was observed in 15 cases (65%). The tissue samples from younger patients (≤ 50 years) were mostly positive in 72.7% (8/11) of cases. High grade GS (≥ 3) tumors were CCR7-positive in 71% cases. The malignant cells present in lymph nodes were CCR7 positive in 100% cases. The bioinformatic analysis showed a high CCR7 expression associated with the presence of metastasis (FC = 2.6, p = 0.03) in the Cancer Genome Atlas (TCGA) PCa cohort (PRAD). Conclusion: We showed that CCR7 expression in tumors from young patients is associated with the early onset of the disease and could also be related to lymph node metastasis.
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
Title: EXPRESSION OF CHEMOKINE (C-C MOTIF) RECEPTOR 7 IN PROSTATE CANCER TISSUE OF YOUNG PATIENTS AND IN METASTATIC CANCER CELLS
Description:
Background: Chemokine (C-C motif) receptor 7 (CCR7) is a chemokine receptor involved in the carcinogenesis of several types of tumors due to its promoting action in epithelial-mesenchymal transition events, invasion, angiogenesis and metastasis.
However, its role in prostate cancer (PCa) remains unclear.
Aim: To evaluate CCR7 expression by immunohistochemistry in prostate tumors from young patients and to determine the possible relationship with the clinicopathological characteristics.
Materials and Methods: We analyzed retrospectively paraffin-embedded tissue sections from 23 young PCa (≤ 55 years old) patients and evaluated the transcriptomic expression in the TCGA database.
Results: Expression of CCR7 was observed in 15 cases (65%).
The tissue samples from younger patients (≤ 50 years) were mostly positive in 72.
7% (8/11) of cases.
High grade GS (≥ 3) tumors were CCR7-positive in 71% cases.
The malignant cells present in lymph nodes were CCR7 positive in 100% cases.
The bioinformatic analysis showed a high CCR7 expression associated with the presence of metastasis (FC = 2.
6, p = 0.
03) in the Cancer Genome Atlas (TCGA) PCa cohort (PRAD).
Conclusion: We showed that CCR7 expression in tumors from young patients is associated with the early onset of the disease and could also be related to lymph node metastasis.

Related Results

Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract BACKGROUND: Multiple steps and factors are involved in prostate carcinogenesis and tumor progression. The early studies have found that tumor-associated mac...
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract Background: Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide. It is the third most common cancer in men in Algeri...
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein, which our group first cloned and characterized in myeloid cells and mapp...
Abstract 1423: SSX-2 expression and function in metastatic prostate cancer
Abstract 1423: SSX-2 expression and function in metastatic prostate cancer
Abstract Background: The SSX family of proteins, whose function and aberrant expression in prostate cancer isn't fully understood, may lead to disease progression fr...
The bovine chemokine receptors and their mRNA abundance in mononuclear phagocytes
The bovine chemokine receptors and their mRNA abundance in mononuclear phagocytes
AbstractBackgroundThe chemokine and chemokine receptor families play critical roles in both the healthy and diseased organism mediating the migration of cells. The chemokine system...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Metastatic colorectal cancer from an epidemiological and immunological perspective
Metastatic colorectal cancer from an epidemiological and immunological perspective
<p dir="ltr">Colorectal cancer (CRC) is the third most common type of cancer and around 8000 persons in Sweden get the diagnosis each year. One in five will have metastases a...
Metastatic colorectal cancer from an epidemiological and immunological perspective
Metastatic colorectal cancer from an epidemiological and immunological perspective
<p dir="ltr">Colorectal cancer (CRC) is the third most common type of cancer and around 8000 persons in Sweden get the diagnosis each year. One in five will have metastases a...

Back to Top